3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol Basic information
- Product Name:
- 3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol
- Synonyms:
-
- 3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol
- 3,3,-(2,4-diaminopteridine-6,7-diyl)diphenol
- TG100-115;TG100115;TG100 115
- 6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamine
- 3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol TG100-115
- TG100-115, >=98%
- TG100115; TG100 115
- CS-427
- CAS:
- 677297-51-7
- MF:
- C18H14N6O2
- MW:
- 346.34
- Product Categories:
-
- Inhibitors
- Akt
- mTOR
- PI3K
- APIs
- Mol File:
- 677297-51-7.mol
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol Chemical Properties
- Boiling point:
- 699.6±65.0 °C(Predicted)
- Density
- 1.516±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- insoluble in H2O; insoluble in EtOH; ≥3.46 mg/mL in DMSO
- form
- Yellow powder solid.
- pka
- 8.54±0.10(Predicted)
- color
- Light yellow to yellow
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol Usage And Synthesis
Uses
TG100-115 is a potent and selective phosphoinositide 3-kinase gamma/delta (PI3Kγ/δ) inhibitor. It can provide potent cardioprotection, reduce infarct development, and preserve myocardial function.
Definition
ChEBI: 3-[2,4-diamino-7-(3-hydroxyphenyl)-6-pteridinyl]phenol is a member of pteridines.
Biological Activity
tg100-115 is an inhibitor of pi3kγ and pi3kδ with ic50 values of 83 nm and 235 nm, respectively. tg100-115 shows no obvious activity against pi3kα and pi3kβ [1].tg100-115 remarkably reduced eosinophil accumulation, balf levels of classic th2 cytokine il-13, perivascular and peribronchial leukocyte accumulations, and bronchiolar mucin accumulation in a murine model. besides, tg100-115 showed to reduce airway hyper-responsiveness (ahr) by approximately 50% in asthmatic mice. moreover, tg100-115 has been reported to reduce both smoke-and lps-induced neutrophil and lps-induced classic th1 cytokine tnfα accumulations in mice [2].
target
PI3K-γ
References
[1] doukas j1, wrasidlo w, noronha g, dneprovskaia e, fine r, weis s, hood j, demaria a, soll r, cheresh d. hosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury. proc natl acad sci u s a. 2006 dec 26;103(52):19866-71.
[2] doukas j1, eide l, stebbins k, racanelli-layton a, dellamary l, martin m, dneprovskaia e, noronha g, soll r, wrasidlo w, acevedo lm, cheresh da. aerosolized phosphoinositide 3-kinase gamma/delta inhibitor tg100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease. j pharmacol exp ther. 2009 mar;328(3):758-65.
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenolSupplier
- Tel
- sales@boylechem.com
- Tel
- +86-21-20908456
- sales@BioChemBest.com
- Tel
- +86 (531) 88811783
- sales@trio-pharmatech.com (International market)
- Tel
- 0411-62910999 13889544652
- meilunui@163.com
- Tel
- 86-21-34053660
- sale@labgogo.com
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol(677297-51-7)Related Product Information
- N-(tert-Butyl)-3-[[5-methyl-2-[[4-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide
- Fedratinib
- CCT 137690
- Tariquidar
- (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid
- 5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione
- Torin 1
- Telaprevir
- Avagacestat (BMS-708163)
- RO4929097
- CUDC-101
- Brivanib alaninate
- AC480 (BMS-599626)
- Capmatinib
- Selumetinib
- CZC24832
- SGX-523
- IPI 145